Literature DB >> 28497986

Traditional Chinese Medicine on the Treatment of Coronary Heart Disease in Recent 20 Years.

Ping Gong1, Yue Li1, Chengzeng Yao1, Hui Guo1, Hui Hwang2, Xiaobing Liu3, Yan Xu1, Xiaolong Wang1.   

Abstract

OBJECTIVE: To analyze the patterns and differences of Chinese herbs in the treatment of coronary heart disease (CHD) in different time periods and different regions in recent 20 years.
DESIGN: The literature of controlled clinical trials that focuses on Chinese herbs treating CHD published in China National Knowledge Internet and Wanfang database from January 1, 1996 to December 31, 2015 were screened to analyze the patterns of herb utilization using SPSS 21.0.
RESULTS: A total of 1250 articles were enrolled in total covering 29 regions. There were 242 kinds of single herbs, 18 categories, mentioned a total of 11,594 times. In Northeast China, North China, South China, Central China, and Southwest China the most frequently used herb was Radix Salviae Miltiorrhizae, but in East China and Northwest China, the most frequently used herb was Rhizoma Chuanxiong. The most frequently used herb category in North China, Central China, Southwest China, and Northwest China was herbs to invigorate blood, but in Northeast China, East China, and South China the most frequently used herb category was herbs to tonify.
CONCLUSION: Single herbs and herb categories to treat CHD in Traditional Chinese Medicine differed from time to time and from region to region.

Entities:  

Keywords:  Traditional Chinese Medicine; coronary heart disease; patterns of herb utilization

Mesh:

Substances:

Year:  2017        PMID: 28497986     DOI: 10.1089/acm.2016.0420

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  11 in total

1.  Effect of methanol extract of Salviae miltiorrhizae Radix in high-fat diet-induced hyperlipidemic mice.

Authors:  Chiyeon Lim; Sehyun Lim; Byoungho Lee; Buyeo Kim; Suin Cho
Journal:  Chin Med       Date:  2017-10-13       Impact factor: 5.455

2.  Expert Consensus of Syndrome Differentiation for Phlegm Turbidity Syndrome for Coronary Heart Disease.

Authors:  Xin-Lin Chen; Xiao-Qi Liu; Rong Xie; Dan-Hong Peng; Yan-Ping Wang; Xuan Zhou; Bin Wang; Chuan-Wei Mo; Qian Xu; Xiantao Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-02       Impact factor: 2.629

3.  Ginsenoside Re Improves Isoproterenol-Induced Myocardial Fibrosis and Heart Failure in Rats.

Authors:  Quan-Wei Wang; Xiao-Feng Yu; Hua-Li Xu; Xue-Zhong Zhao; Da-Yuan Sui
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-01       Impact factor: 2.629

4.  Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.

Authors:  Yan Jiang; Qi He; Tianqing Zhang; Wang Xiang; Zhiyong Long; Shiwei Wu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

5.  Adjuvant treatment of coronary heart disease angina pectoris with Chinese patent medicine: A prospective clinical cohort study.

Authors:  Yijia Liu; Zhu Li; Dandan Shen; Yanqi Song; Mengnan Huang; Xiaoxue Xue; Jing Xie; Ziyi Jiao; Shuming Gao; Yilan Xu; Shan Gao; Xianliang Wang; Qiang Xu; Sheng Gao; Chunjie Li; Lin Li; Kaijun Niu; Chunquan Yu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

6.  A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.

Authors:  Yiru Wang; Yiyi Zhang; Yiyue Du; Ying Yang; Jing Wei; Na Zhang; Meijiao Mao; Wenting Du; Ping Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Pharmacological Network Reveals the Active Mechanism of Qi-Replenishing, Spleen-Strengthening, Phlegm-Dispelling, and Blood-Nourishing Fufang on Coronary Heart Disease.

Authors:  Fan Zhang; Yue Liu; Sicheng Zheng; Boyi Dang; Jianan Wang; Zhe Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-29       Impact factor: 2.629

8.  Efficacy of Yangxin Recipe in Combination with Conventional Western Medicine in Treatment of Angina Pectoris of Coronary Heart Disease.

Authors:  Jiali Liu; Yaorong Dong; Xiaozhen Hu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

9.  Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials.

Authors:  Shujuan Li; Shasha Duan; Yuzhen Ning; Hongmei Zhang; Qi Zheng
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

10.  Tongguan capsule-derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts.

Authors:  Shiyu Ma; Jin Ma; Liheng Guo; Junqi Bai; Shuai Mao; Minzhou Zhang
Journal:  J Cell Mol Med       Date:  2018-11-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.